Urine screening for chlamydia trachomatis during pregnancy

Scott W. Roberts, Jeanne S. Sheffield, Don D. McIntire, James M. Alexander

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: To compare the rates of Chlamydia trachomatis detection using urine and cervical secretions from pregnant women at our institution. Methods: A large cross-sectional sample of pregnant women (N=2,018) at 35-37 weeks of gestation were tested for C trachomatis with both endocervical and urine sampling using the Aptima Combo 2 Assay. Results: A prevalence of 4.3% and 4.1% were found for Chlamydia endocervical and urine samples, respectively. There was no difference between the two tests by McNemar's test (-0.02%, 0.32%; P=.083). There was excellent correlation between the tests found by the κ statistic (0.982 [0.961-1.000]). Conclusion: Urine sampling for C trachomatis is equivalent to endocervical sampling in pregnancy using the Aptima 2 Combo Assay.

Original languageEnglish (US)
Pages (from-to)883-885
Number of pages3
JournalObstetrics and Gynecology
Volume117
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Chlamydia trachomatis
Urine
Pregnancy
Pregnant Women
Chlamydia

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Urine screening for chlamydia trachomatis during pregnancy. / Roberts, Scott W.; Sheffield, Jeanne S.; McIntire, Don D.; Alexander, James M.

In: Obstetrics and Gynecology, Vol. 117, No. 4, 04.2011, p. 883-885.

Research output: Contribution to journalArticle

Roberts, Scott W. ; Sheffield, Jeanne S. ; McIntire, Don D. ; Alexander, James M. / Urine screening for chlamydia trachomatis during pregnancy. In: Obstetrics and Gynecology. 2011 ; Vol. 117, No. 4. pp. 883-885.
@article{c02c9a0ed9c74b38ac5e5302defbf3de,
title = "Urine screening for chlamydia trachomatis during pregnancy",
abstract = "Objective: To compare the rates of Chlamydia trachomatis detection using urine and cervical secretions from pregnant women at our institution. Methods: A large cross-sectional sample of pregnant women (N=2,018) at 35-37 weeks of gestation were tested for C trachomatis with both endocervical and urine sampling using the Aptima Combo 2 Assay. Results: A prevalence of 4.3{\%} and 4.1{\%} were found for Chlamydia endocervical and urine samples, respectively. There was no difference between the two tests by McNemar's test (-0.02{\%}, 0.32{\%}; P=.083). There was excellent correlation between the tests found by the κ statistic (0.982 [0.961-1.000]). Conclusion: Urine sampling for C trachomatis is equivalent to endocervical sampling in pregnancy using the Aptima 2 Combo Assay.",
author = "Roberts, {Scott W.} and Sheffield, {Jeanne S.} and McIntire, {Don D.} and Alexander, {James M.}",
year = "2011",
month = "4",
doi = "10.1097/AOG.0b013e3182107d47",
language = "English (US)",
volume = "117",
pages = "883--885",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Urine screening for chlamydia trachomatis during pregnancy

AU - Roberts, Scott W.

AU - Sheffield, Jeanne S.

AU - McIntire, Don D.

AU - Alexander, James M.

PY - 2011/4

Y1 - 2011/4

N2 - Objective: To compare the rates of Chlamydia trachomatis detection using urine and cervical secretions from pregnant women at our institution. Methods: A large cross-sectional sample of pregnant women (N=2,018) at 35-37 weeks of gestation were tested for C trachomatis with both endocervical and urine sampling using the Aptima Combo 2 Assay. Results: A prevalence of 4.3% and 4.1% were found for Chlamydia endocervical and urine samples, respectively. There was no difference between the two tests by McNemar's test (-0.02%, 0.32%; P=.083). There was excellent correlation between the tests found by the κ statistic (0.982 [0.961-1.000]). Conclusion: Urine sampling for C trachomatis is equivalent to endocervical sampling in pregnancy using the Aptima 2 Combo Assay.

AB - Objective: To compare the rates of Chlamydia trachomatis detection using urine and cervical secretions from pregnant women at our institution. Methods: A large cross-sectional sample of pregnant women (N=2,018) at 35-37 weeks of gestation were tested for C trachomatis with both endocervical and urine sampling using the Aptima Combo 2 Assay. Results: A prevalence of 4.3% and 4.1% were found for Chlamydia endocervical and urine samples, respectively. There was no difference between the two tests by McNemar's test (-0.02%, 0.32%; P=.083). There was excellent correlation between the tests found by the κ statistic (0.982 [0.961-1.000]). Conclusion: Urine sampling for C trachomatis is equivalent to endocervical sampling in pregnancy using the Aptima 2 Combo Assay.

UR - http://www.scopus.com/inward/record.url?scp=79953174960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953174960&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e3182107d47

DO - 10.1097/AOG.0b013e3182107d47

M3 - Article

C2 - 21422860

AN - SCOPUS:79953174960

VL - 117

SP - 883

EP - 885

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -